About Us
PanTHERA CryoSolutions is a Canadian corporation that designs and manufactures cryopreservation solutions for cells, tissues and organs for research and clinical markets. Our patented ice recrystallization inhibitor (IRI) technology exceeds competitors’ products by providing superior cryopreservation and increasing post-thaw cell recovery and function for our customers. The technology enables the use of less costly storage and transportation systems limiting liquid nitrogen use for some cell therapy applications.
Our Mission
PanTHERA’s mission is to apply its scientific excellence to the development of evidence-based products that control ice crystal formation and protect cells, tissues, and organs from freezing damage as well as reducing toxicity, improving stability and post-thaw functionality. As a forward-looking organization we are constantly expanding our technology to contribute to improving cell-based research, agriculture, biodiversity preservation, aquaculture, and human medicine.
Our Partners
In December 2020, PanTHERA CryoSolutions and BioLife Solutions entered into a strategic partnership for the co-development of PanTHERA’s IRI technology and its use in the preservation of cells in research and cell and gene therapies. BioLife is a leading supplier of class-defining cell and gene therapy bioproduction tools and services.
For more information please contact: invest@pantheracryo.com
News & Events
PanTHERA Feature: David Lewandowski, Director of Business Development at AmplifyBio
Scientist Feature: Dr. Esme Dijke, Director at the Histocompatibility Laboratory and Assistant Professor for Lab Medicine and Pathology.
Unlocking Quality: Understanding GMP Grade Products
Cryopreservation: A Key to Conserving Biodiversity
Scientist Feature: Dr. Anna Jezierski, Research Officer with the Human Health Therapeutics Research Centre at the NRC
Revolutionizing Agriculture: The Crucial Role of Cryopreservation
The Vital Role of Ice Recrystallization Inhibitors in Cold Chain Management
Ice Recrystallization Inhibitors: A Promising Breakthrough in Cryopreservation
PanTHERA CryoSolutions Press Coverage
GlycoNet and PanTHERA CryoSolutions’ Journey: From Bench to Bedside
